En Es
Categories

Industry News


Siemens Healthineers Receives Recognition AI Applications in Radiology

By Medimaging International staff writers
05 Aug 2019

Image: The BioMatrix technology on MRI platforms features respiratory, beat and kinetic sensors (Photo courtesy of Siemens Healthineers).Based on its recent analysis of the global precision imaging market, Frost & Sullivan (Santa Clara, CA, USA), a growth strategy consulting and research firm, has recognized Siemens Healthineers (Erlangen, Germany) with the 2019 Global Visionary Innovation Leadership Award for leading the effort to establish imaging as an active contributor to precision medicine.

Siemens Healthineers leverages several advances in imaging equipment, imaging IT, and informatics to deliver higher image quality so radiologists may extract deeper insights from imaging studies across modalities. The company was one of the first users of early generation machine learning algorithms, and it continues to advance its AI applications in radiology and other clinical areas to address issues such as variability.

Siemens Healthineers is pushing the boundaries of precision imaging with its planned MR fingerprinting, which is designed to be a disruptive approach to quantitative data acquisition. Using the simultaneously acquired multi-parametric data, quantitative information is planned to provide prognostic information. It also boasts PET-CT quantification capability, which enables accuracy when imaging a tumor to determine its size, location, and volume. Furthermore, the company supports personalized ultrasound imaging by developing clinical applications for real-time assessment adapted to specific diseases.

Siemens Healthineers also partners with various vendors to fill the gaps in its competencies instead of relying solely on its strengths. For example, it introduced syngo.via Open Apps and opened its platform to third-party applications, and it has partnered with Materialise NV to present the Mimics inPrint software to radiologists in hospitals. This allows radiologists to work with surgical teams by helping 3D print personalized anatomical models, especially for complex anatomical pathologies, to aid in surgical planning, patient communication, or even training.

"Siemens Healthineers has developed the BioMatrix technology on its magnetic resonance imaging (MRI) platforms, featuring respiratory, beat, and kinetic sensors. These are devices with sensitive motion correction capabilities that can even track a patient's breathing and incorporate that information during image reconstruction to provide precise imaging results," said Siddharth Saha, Vice President, Research, Transformational Health. "In addition, in Computed Tomography its Fully Assisting Scanner Technologies (FAST) 3D camera tracks patient position and motion to ensure excellent image quality and standardization of image acquisition protocols."



E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
Gold member
More info

More articles about Siemens Healthineers

15 Oct 2019
Siemens Healthineers’ AI-Based Chest CT Software Receives US FDA Clearance
The US Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent software assistant from Siemens Healthineers that brings artificial intelligence (AI) to computed tomography (CT).
Read More
13 Aug 2019
Siemens Healthineers' Acquires Corindus to Enhance Robotic-Assisted Interventions
Siemens Healthineers AG has entered into a merger agreement with Corindus Vascular Robotics, Inc. to acquire the company, which offers a robotic treatment platform for the major vascular therapeutic markets, including coronary, peripheral vascular and neurovascular interventions.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
06 Jun 2018
Siemens Healthineers and ScreenPoint Medical to Develop AI-Based Apps
Siemens Healthineers and ScreenPoint Medical have entered into a partnership to develop artificial intelligence (AI)-based applications for breast imaging. As part of the arrangement, Siemens Healthineers will also acquire a strategic minority stake in ScreenPoint Medical.
Read More
26 Apr 2018
Siemens Healthineers Launches Thermocycler with AI-Powered Software
Siemens Healthineers launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.
Read More
27 Feb 2018
Siemens Healthineers AG IPO Planned for First Half of 2018
Global technology powerhouse Siemens AG and its separately managed healthcare business, Siemens Healthineers have announce that the planned IPO of Siemens Healthineers AG is expected to be completed in the first half of calendar year 2018, subject to capital market conditions.
Read More
18 Jan 2018
Siemens Healthineers Strategy 2025 to Focus on AI
Siemens Healthineers has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.
Read More

Additional news

25 Nov 2019
LANDAUER and RaySafe Exhibit New Products and Services at RSNA 2019
 LANDAUER (Glenwood, IL, USA) and RaySafe (Billdal, Sweden) showcased several new products and services at the Radiological Society of North America (RSNA) 2019 Annual Meeting held on December 1-5 at McCormick Place in Chicago, USA.
Read More
07 Nov 2019
Global Automated Breast Ultrasound Systems Market to Surpass USD 1.8 Billion by 2025
The global automated breast ultrasound systems (ABUS) market was valued at over USD 0.68 billion in 2018 and is projected to grow at a CAGR 16.1% during the forecast period, 2019-2025 to surpass USD 1.8 billion by 2025, driven by increasing government expenditure and rising awareness about breast cancer. Initiatives such as free check-up camps and symposiums for raising awareness regarding early detection and diagnosis of breast cancer will lead to greater adoption of ABUS in the coming years. However, stringent regulations and guidelines for the approval of ABUS, coupled with the high cost of diagnostic procedure, could hamper the market growth during the forecast period.
Read More
07 Nov 2019
CT System Receives FDA Clearance for AI-Based Image Reconstruction Technology
Canon Medical Systems USA, Inc. (Tustin, CA, USA; www.us.medical.canon) has received 510(k) clearance for its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion Precision, further expanding access to its new deep convolutional neural network (DCNN) image reconstruction technology. The technology, which is now available on Canon’s Aquilion Precision and Aquilion ONE/GENESIS Edition CT systems, uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal, thus improving CT image reconstruction.
Read More
07 Nov 2019
AI-Powered MRI Image Enhancement Software Receives FDA Clearance
A new image processing software that utilizes proprietary deep learning algorithms to bring the latest imaging enhancement technology to existing scanners has received 510(k) clearance from the US Food and Drug Administration (FDA). The software named SubtleMR uses denoising and resolution enhancement to improve image quality and has been developed by Subtle Medical (Menlo Park, CA, USA; www.subtlemedical.com), a healthcare technology company focused on improving the quality, efficiency, and accessibility of medical imaging.
Read More
06 Nov 2019
UCSF Launches Artificial Intelligence Center to Advance Medical Imaging
The University of California San Francisco {(UCSF) San Francisco, CA, USA; www.ucsf.edu} has announced the launch of a new center to accelerate the application of artificial intelligence (AI) technology to radiology, leveraging advanced computational techniques and industry collaborations to improve patient diagnoses and care. The Center for Intelligent Imaging, or ci2, will develop and apply AI to devise powerful new ways to look inside the body and to evaluate health and disease. The center aims to enable transformation via intelligent radiology, with the goal of again collaborating with the industry to become of the first institutions to bring medical imaging AI to the bedside.
Read More
06 Nov 2019
Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025
The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 6.5% during the forecast period, 2018-2025 to reach a value of over USD 2.1 billion by 2025, driven mainly by the Bench Top segment which is anticipated to bring in healthy gains and add significant momentum to the market growth. The Bench Top segment is projected to grow at a CAGR of over 6.4% during the forecast period.
Read More
06 Nov 2019
AI-Powered Diagnostics Software Guides Cardiologists during Angiography
Researchers are in the initial stages of a pivotal multi-center clinical trial to demonstrate the efficacy of AutocathFFR, a fully automated system that detects stenoses (narrowing) in the coronary arteries surrounding the heart. AutocathFFR provides cardiologists with the relevant physiological parameters that can help them in assessing the severity of their patients' condition and devise the optimal treatment strategy.
Read More
06 Nov 2019
IoT-Enabled Healthcare Equipment Market Projected to Reach USD 69.7 Billion by 2023
The global IoT-enabled healthcare equipment market is projected to grow at the rate of 29.9% annually from USD 18.8 billion in 2018 to USD 69.7 billion in 2023, driven by digitization during the forecast period. Medical devices companies are transforming from device or consumable providers to disease and care management organizations. Digitization in acute or chronic care is greatly aided by IoT-enabled medical devices, such as subcutaneous drug delivery units, continuous glucose monitors and vitals monitoring equipment. The emergence of digital enterprises such as Google and Apple in the consumer health space has led to development of new opportunities and innovations for medical devices companies.
Read More
05 Nov 2019
AI-Driven Software Uses CT Scans to Determine Extent of Brain Injury in Stroke Patients
A new study has shown that an artificial intelligence (AI) driven software can reliably tell doctors how much brain is injured in stroke patients using universally available CT scans, without the need for more complex advanced imaging.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions